250 related items for PubMed ID: 8719545
21. Preeclampsia associated focal and segmental glomerulosclerosis and glomerular hypertrophy: a morphometric analysis.
Nochy D, Heudes D, Glotz D, Lemoine R, Gentric D, Bruneval P, Bariéty J.
Clin Nephrol; 1994 Jul; 42(1):9-17. PubMed ID: 7923975
[Abstract] [Full Text] [Related]
22. Diagnostic and prognostic significance of glomerular epithelial cell vacuolization and podocyte effacement in children with minimal lesion nephrotic syndrome and focal segmental glomerulosclerosis: an ultrastructural study.
Chiang ML, Hawkins EP, Berry PL, Barrish J, Hill LL.
Clin Nephrol; 1988 Jul; 30(1):8-14. PubMed ID: 3061695
[Abstract] [Full Text] [Related]
23. Glomerular size and glomerulosclerosis: relationships to disease categories, glomerular solidification, and ischemic obsolescence.
Hughson MD, Johnson K, Young RJ, Hoy WE, Bertram JF.
Am J Kidney Dis; 2002 Apr; 39(4):679-88. PubMed ID: 11920332
[Abstract] [Full Text] [Related]
24. Tubulointerstitial lesions in non-insulin dependent diabetes mellitus.
Ueno M, Kawashima S, Nishi S, Shimada H, Karasawa R, Suzuki Y, Maruyama Y, Arakawa M.
Kidney Int Suppl; 1997 Dec; 63():S191-4. PubMed ID: 9407456
[Abstract] [Full Text] [Related]
25. The clinical significance of the glomerular location of segmental lesions in focal segmental glomerulosclerosis.
Morita M, White RH, Coad NA, Raafat F.
Clin Nephrol; 1990 May; 33(5):211-9. PubMed ID: 2354557
[Abstract] [Full Text] [Related]
26. Renal cortical interstitial volume in mesangial IgA nephropathy. Dissociation from creatinine clearance in serially biopsied patients.
Bennett WM, Walker RG, Kincaid-Smith P.
Lab Invest; 1982 Oct; 47(4):330-5. PubMed ID: 7120920
[Abstract] [Full Text] [Related]
27. [Role of podocyte damage in the pathogenesis of glomerulosclerosis and tubulointerstitial lesions: findings in the growth hormone transgenic mouse model of progressive nephropathy].
Wanke R, Wolf E, Brem G, Hermanns W.
Verh Dtsch Ges Pathol; 2001 Oct; 85():250-6. PubMed ID: 11894406
[Abstract] [Full Text] [Related]
28. The application of electron microscopic morphometry as a helpful method in the diagnosis of focal segmental glomerulosclerosis (FSGS) early phase. II. Clinical usefulness of electron microscopic morphometric studies in cases of minimal change disease (MCD) and mesangioproliferative glomerulonephritis (GNMES) with suspicion of progression into focal segmental glomerulosclerosis (FSGS).
Woźniak A, Bortkiewicz E, Salwa-Zurawska W, Kaczmarek E, Maciejewski J.
Pol J Pathol; 2001 Oct; 52(1-2):37-46. PubMed ID: 11505679
[Abstract] [Full Text] [Related]
29. Histomorphological classification of focal segmental glomerulosclerosis: a critical evaluation of clinical, histologic and morphometric features.
Das P, Sharma A, Gupta R, Agarwal SK, Bagga A, Dinda AK.
Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):1008-16. PubMed ID: 22982914
[Abstract] [Full Text] [Related]
30. [An analysis of the clinical and pathological manifestations of adult idiopathic focal segmental glomerulosclerosis].
Liu G, Zhang ZY, Zou WZ, Wang HY.
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):150-3. PubMed ID: 15100732
[Abstract] [Full Text] [Related]
31. The effect of proteinase inhibitors on glomerular albumin permeability induced in vitro by serum from patients with idiopathic focal segmental glomerulosclerosis.
Carraro M, Zennaro C, Artero M, Candiano G, Ghiggeri GM, Musante L, Sirch C, Bruschi M, Faccini L.
Nephrol Dial Transplant; 2004 Aug; 19(8):1969-75. PubMed ID: 15187198
[Abstract] [Full Text] [Related]
32. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
Baranowska-Daca E, Choi YJ, Barrios R, Nassar G, Suki WN, Truong LD.
Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
[Abstract] [Full Text] [Related]
33. Glomerular metalloprotease activity modulates the development of focal segmental glomerulosclerosis.
Sagar S, Gibbons N, Valderrama E, Singhal PC.
Clin Nephrol; 1995 Dec; 44(6):356-61. PubMed ID: 8719546
[Abstract] [Full Text] [Related]
34. Glomerular malondialdehyde levels in patients with focal and segmental glomerulosclerosis and minimal change disease.
Nezhad ST, Momeni B, Basiratnia M.
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):886-91. PubMed ID: 20814126
[Abstract] [Full Text] [Related]
35. Correlation of kidney biopsy findings and clinical manifestations of primary focal and segmental glomerulosclerosis.
Taheri D, Chehrei A, Samanianpour P, Hassanzadeh A, Sadrarhami S, Seyrafian S.
Saudi J Kidney Dis Transpl; 2009 May; 20(3):417-23. PubMed ID: 19414944
[Abstract] [Full Text] [Related]
36. Increased glomerular and extracellular malondialdehyde levels in patients and rats with focal segmental glomerulosclerosis.
Kuo HT, Kuo MC, Chiu YW, Chang JM, Guh JY, Chen HC.
Eur J Clin Invest; 2005 Apr; 35(4):245-50. PubMed ID: 15816993
[Abstract] [Full Text] [Related]
37. Two different pathways of glomerular enlargement in adults with focal and segmental glomerulosclerosis: a morphometric study.
Matsumae T, Fukuzaki M, Takebayashi S, Naito S.
Am J Nephrol; 1998 Apr; 18(1):21-7. PubMed ID: 9481435
[Abstract] [Full Text] [Related]
38. Glomerular tip lesion in minimal change nephropathy: a study of autopsies before 1950.
Haas M, Yousefzadeh N.
Am J Kidney Dis; 2002 Jun; 39(6):1168-75. PubMed ID: 12046027
[Abstract] [Full Text] [Related]
39. Secondary focal segmental glomerulosclerosis in non-obese patients with increased muscle mass.
Schwimmer JA, Markowitz GS, Valeri AM, Imbriano LJ, Alvis R, D'Agati VD.
Clin Nephrol; 2003 Oct; 60(4):233-41. PubMed ID: 14579937
[Abstract] [Full Text] [Related]
40. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation.
Hill GS, Heudes D, Bariéty J.
Kidney Int; 2003 Mar; 63(3):1027-36. PubMed ID: 12631084
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
